
An AI based accessibility tool enables websites to be accessible among people with hearing or vision impairments, motor impaired, color blind, dyslexia, cognitive & learning impairments, seizure & epileptic, ADHD, elderly, and Parkinson. It installs in just 2 minutes. It reduces the risk of time-consuming accessibility lawsuits by improving accessibility compliance for the standards WCAG 2.0, 2.1, 2.2, ADA, Section 508, European EAA EN 301 549, Canada ACA, California Unruh, Israeli Standard 5568, Australian DDA, UK Equality Act, Ontario AODA, Indian RPD Act, GIGW 3.0, France RGAA, German BITV, Brazilian Inclusion law LBI 13.146/2015, Spain UNE 139803:2012, JIS X 8341, Italian Stanca Act, Switzerland DDA & more. It supports GDPR, HIPAA, CCPA, SOC Type 2, ISO 9001:2015, & ISO 27001:2022.
It supports 190+ languages. It is a cornerstone of improving web accessibility through its ease of use for companies of all sizes and with the help of paid add-ons like manual accessibility audit, remediation, PDF accessibility remediation, VPAT/ ACR, white label subscription, and live site translation, SkynetAccessibility Scanner, and video subtitle.
Top features of the All in One Accessibility:
- AI Screen Reader
- Accessibility statement
- Accessibility interface for UI design fixes
- Free Accessibility Statement Generator
- Voice Navigation
- Talk & Type
- Libras (Brazilian Portuguese) Sign Language
- Dashboard Automatic accessibility score
- AI based Image Alternative Text remediation
- AI based Text to Speech Screen Reader
- Select Screen Reader Voice
- Auto-detect language
- Keyboard navigation adjustments
- Content, Color, Contrast, Orientation Adjustments
- Custom widget color, position, icon size, type
- Dedicated support
Learn more
AI Agents can’t manage your network without context. NetBrain delivers it.
NetBrain provides a proven, safe path to Agentic NetOps, backed by an AI-powered platform informed by network context, real customer outcomes, and enterprise network expertise.
Learn more
BrainSightAI
BrainSightAI is an innovative health technology firm that harnesses the power of artificial intelligence and machine learning to transform the field of brain mapping through AI-driven connectomics, allowing for the creation of customized brain maps. The VoxelBox product line employs these AI techniques to produce individualized brain maps tailored to each patient's needs. These advanced tools are specifically designed to facilitate pre-surgical preparation and enhance patient outcomes for those suffering from brain tumors and various neurological issues. Collaborating with top hospitals across the country, BrainSightAI is engaged in clinical trials that explore a range of brain-related ailments such as Alzheimer's disease, brain tumors, psychiatric disorders, Parkinson's disease, and stroke. Committed to pushing the boundaries of brain science, our overarching goal is to improve quality of life by offering state-of-the-art resources that deepen our understanding of the human brain and its complexities. By continually refining our technology and methodologies, we aspire to make significant contributions to the medical community and the lives of patients.
Learn more
CANTAB
The Cambridge Neuropsychological Test Automated Battery (CANTAB), which was initially created at the University of Cambridge, provides highly accurate and objective assessments of cognitive abilities that are linked to neural networks. With the capability to detect variations in neuropsychological performance, CANTAB encompasses a wide array of tests that evaluate working memory, learning, and executive function, as well as visual, verbal, and episodic memory; attention, information processing, and reaction time; social and emotional recognition, decision-making, and response control. These cognitive evaluations serve as crucial instruments for unraveling the complexities of specific brain functions associated with various disorders and conditions, offering valuable insights into their underlying causes, facilitating the early detection of symptoms, and assessing the impact of interventions aimed at enhancing brain health. By utilizing the CANTAB, researchers and clinicians can better understand cognitive impairments, leading to more effective strategies for treatment and support.
Learn more